Data / Form D filings / ALIOS BIOPHARMA INC
ALIOS BIOPHARMA INC: Form D filings
ALIOS BIOPHARMA INC, a pharmaceuticals company in South San Francisco, CA, filed 3 Form D notices with the SEC between 2009 and 2014. The latest, on May 19, 2014, reports $41 million sold of a $41 million offering to 14 investors.
Find out what ALIOS BIOPHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 260 EAST GRAND AVENUE, 2ND FLOOR, South San Francisco, CA, 94080
- Phone
- (650) 635-5500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1380990
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2014 | New notice | $41,000,001 | $41,000,001 | $0 | 14 | Apr 2, 2014 | sec.gov |
| Jan 29, 2010 | Amendment | $34,241,356 | $30,241,356 | $4,000,000 | 18 | Dec 23, 2008 | sec.gov |
| Jun 19, 2009 | Amendment | $11,041,356 | $11,041,356 | $0 | 18 | Dec 23, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Hirth | Director | |
| Jack Nielsen | Director | |
| Campbell Murray | Director | |
| Lawrence Blatt | Executive Officer, Director | |
| John Donovan | Executive Officer | |
| Leonid Beigelman | Executive Officer | |
| Jens Eckstein | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 19, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ALIOS BIOPHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.